0001104659-13-067974.txt : 20130904 0001104659-13-067974.hdr.sgml : 20130904 20130904160140 ACCESSION NUMBER: 0001104659-13-067974 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130829 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20130904 DATE AS OF CHANGE: 20130904 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CYANOTECH CORP CENTRAL INDEX KEY: 0000768408 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 911206026 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-14602 FILM NUMBER: 131077914 BUSINESS ADDRESS: STREET 1: 73-4460 QUEEN KAAHUMANU HWY STREET 2: SUITE 102 CITY: KAILUA KONA STATE: HI ZIP: 96740 BUSINESS PHONE: 8083261353 MAIL ADDRESS: STREET 1: 73-4460 QUEEN KAAHUMANU HWY STREET 2: SUITE 102 CITY: KAILUA-KONA STATE: HI ZIP: 96740 8-K 1 a13-20121_18k.htm 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 8-K

 

Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

August 29, 2013

Date of Report: (Date of earliest event reported)

 

Cyanotech Corporation

(Exact name of registrant as specified in its charter)

 

NEVADA
(State or other jurisdiction of
incorporation)

 

000-14602
(Commission File Number)

 

91-1206026
(IRS Employer Identification
Number)

 

73-4460 Queen Kaahumanu Highway, Suite #102, Kailua Kona, HI 96740

(Address of principal executive offices)

 

(808) 326-1353

(Registrant’s telephone number)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 5.07  Submission of Matters to a Vote of Security Holders.

 

On August 29, 2013, the Company held its 2013 Annual Meeting of the Stockholders (the “Annual Meeting”).  The Stockholders re-elected the Board of Directors and approved the proposals listed below.  The final results for the votes regarding each item or proposal are set forth below.  The proposals are described in detail in the Company’s proxy statement filed with the Securities and Exchange Commission on July 19, 2013.

 

1.             To elect five directors among the nominees named in the proxy statement.

 

Name

 

Votes For

 

Votes Withheld

 

Broker Non-Votes

 

Brent D. Bailey

 

2,798,718

 

10,854

 

1,804,936

 

Ralph K. Carlton

 

2,767,592

 

41,980

 

1,804,936

 

Gerald R. Cysewski

 

2,776,963

 

32,609

 

1,804,936

 

Michael A. Davis

 

2,796,975

 

12,597

 

1,804,936

 

Walter B. Menzel

 

2,765,836

 

43,736

 

1,804,936

 

 

2.             To approve, on an advisory basis, the compensation of our Named Executive Officers.

 

Votes For

 

Votes Against

 

Abstentions

 

Broker Non-Votes

 

2,762,480

 

40,411

 

6,681

 

1,804,936

 

 

3.             To approve, on an advisory basis, the Company’s proposal for a three year vote on the frequency of future advisory votes on the compensation of our Named Executive Officers.

 

1 Year

 

2 Years

 

3 Years

 

Abstentions

 

Broker Non-Votes

 

624,754

 

213,774

 

1,960,363

 

10,681

 

1,804,936

 

 

4.             To ratify the selection of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2014.

 

Votes For

 

Votes Against

 

Abstentions

 

Broker Non-Votes

 

4,565,615

 

14,758

 

34,135

 

0

 

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

CYANOTECH CORPORATION

 

 

 

 

Dated: September 4, 2013

/s/ Jole Deal

 

By:

Jole Deal

 

 

Vice President — Finance and

 

 

Administration, Chief Financial

 

 

Officer, Treasurer and Secretary

 

3